BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 36262254)

  • 1. The endoplasmic reticulum membrane protein Sec62 as potential therapeutic target in
    Zimmermann JSM; Linxweiler J; Radosa JC; Linxweiler M; Zimmermann R
    Front Physiol; 2022; 13():1014271. PubMed ID: 36262254
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting cell migration and the endoplasmic reticulum stress response with calmodulin antagonists: a clinically tested small molecule phenocopy of SEC62 gene silencing in human tumor cells.
    Linxweiler M; Schorr S; Schäuble N; Jung M; Linxweiler J; Langer F; Schäfers HJ; Cavalié A; Zimmermann R; Greiner M
    BMC Cancer; 2013 Dec; 13():574. PubMed ID: 24304694
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of SEC62 over-expressing tumors by Thapsigargin and Trifluoperazine.
    Körbel C; Linxweiler M; Bochen F; Wemmert S; Schick B; Meyer M; Maurer H; Menger MD; Zimmermann R; Greiner M
    Biomol Concepts; 2018 May; 9(1):53-63. PubMed ID: 29779013
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of SEC62 in ER maintenance: A link with ER stress tolerance in SEC62-overexpressing tumors?
    Bergmann TJ; Fumagalli F; Loi M; Molinari M
    Mol Cell Oncol; 2017; 4(2):e1264351. PubMed ID: 28401179
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sec62 bridges the gap from 3q amplification to molecular cell biology in non-small cell lung cancer.
    Linxweiler M; Linxweiler J; Barth M; Benedix J; Jung V; Kim YJ; Bohle RM; Zimmermann R; Greiner M
    Am J Pathol; 2012 Feb; 180(2):473-83. PubMed ID: 22197383
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Silencing of the SEC62 gene inhibits migratory and invasive potential of various tumor cells.
    Greiner M; Kreutzer B; Jung V; Grobholz R; Hasenfus A; Stöhr RF; Tornillo L; Dudek J; Stöckle M; Unteregger G; Kamradt J; Wullich B; Zimmermann R
    Int J Cancer; 2011 May; 128(10):2284-95. PubMed ID: 20669223
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of SEC62 as a potential marker for 3q amplification and cellular migration in dysplastic cervical lesions.
    Linxweiler M; Bochen F; Schick B; Wemmert S; Al Kadah B; Greiner M; Hasenfus A; Bohle RM; Juhasz-Böss I; Solomayer EF; Takacs ZF
    BMC Cancer; 2016 Aug; 16(1):676. PubMed ID: 27553742
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Translocon component Sec62 acts in endoplasmic reticulum turnover during stress recovery.
    Fumagalli F; Noack J; Bergmann TJ; Cebollero E; Pisoni GB; Fasana E; Fregno I; Galli C; Loi M; Soldà T; D'Antuono R; Raimondi A; Jung M; Melnyk A; Schorr S; Schreiber A; Simonelli L; Varani L; Wilson-Zbinden C; Zerbe O; Hofmann K; Peter M; Quadroni M; Zimmermann R; Molinari M
    Nat Cell Biol; 2016 Nov; 18(11):1173-1184. PubMed ID: 27749824
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antagonizing Sec62 function in intracellular Ca
    Körner S; Pick T; Bochen F; Wemmert S; Körbel C; Menger MD; Cavalié A; Kühn JP; Schick B; Linxweiler M
    Front Physiol; 2022; 13():880004. PubMed ID: 36045752
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endoplasmic reticulum-resident protein Sec62 drives colorectal cancer metastasis via MAPK/ATF2/UCA1 axis.
    Jin Y; Han Y; Yang S; Cao J; Jiang M; Liang J
    Cell Prolif; 2022 Dec; 55(12):e13253. PubMed ID: 36200182
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of the SEC62 gene in dermato-oncology - impact on tumor cell biology, prognostication, and personalized therapy management.
    Linxweiler M; Müller CSL
    J Dtsch Dermatol Ges; 2022 Sep; 20(9):1187-1199. PubMed ID: 36067526
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genomic and expression analysis of the 3q25-q26 amplification unit reveals TLOC1/SEC62 as a probable target gene in prostate cancer.
    Jung V; Kindich R; Kamradt J; Jung M; Müller M; Schulz WA; Engers R; Unteregger G; Stöckle M; Zimmermann R; Wullich B
    Mol Cancer Res; 2006 Mar; 4(3):169-76. PubMed ID: 16547154
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of 3q oncogene SEC62 as a marker for distant metastasis and poor clinical outcome in invasive ductal breast cancer.
    Takacs FZ; Radosa JC; Linxweiler M; Kasoha M; Bohle RM; Bochen F; Unger C; Solomayer EF; Schick B; Juhasz-Böss I
    Arch Gynecol Obstet; 2019 May; 299(5):1405-1413. PubMed ID: 30747329
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Globular adiponectin alleviates chronic intermittent hypoxia-induced H9C2 cardiomyocytes apoptosis via ER-phagy induction.
    Zhang Q; Zhang X; Ding N; Ge L; Dong Y; He C; Ding W
    Cell Cycle; 2020 Nov; 19(22):3140-3153. PubMed ID: 33092434
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sec62 protein level is crucial for the ER stress tolerance of prostate cancer.
    Greiner M; Kreutzer B; Lang S; Jung V; Cavalié A; Unteregger G; Zimmermann R; Wullich B
    Prostate; 2011 Jul; 71(10):1074-83. PubMed ID: 21557272
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of signal peptide features for substrate specificity in human Sec62/Sec63-dependent ER protein import.
    Schorr S; Nguyen D; Haßdenteufel S; Nagaraj N; Cavalié A; Greiner M; Weissgerber P; Loi M; Paton AW; Paton JC; Molinari M; Förster F; Dudek J; Lang S; Helms V; Zimmermann R
    FEBS J; 2020 Nov; 287(21):4612-4640. PubMed ID: 32133789
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of
    Müller CSL; Pföhler C; Wahl M; Bochen F; Körner S; Kühn JP; Bozzato A; Schick B; Linxweiler M
    Cancers (Basel); 2021 Apr; 13(7):. PubMed ID: 33915997
    [No Abstract]   [Full Text] [Related]  

  • 18. Let's talk about Secs: Sec61, Sec62 and Sec63 in signal transduction, oncology and personalized medicine.
    Linxweiler M; Schick B; Zimmermann R
    Signal Transduct Target Ther; 2017; 2():17002. PubMed ID: 29263911
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of 3q oncogene
    Müller CSL; Kreie L; Bochen F; Pfuhl T; Smola S; Gräber S; Vogt T; Schick B; Linxweiler M
    Oncol Lett; 2019 Feb; 17(2):1768-1776. PubMed ID: 30675236
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of 3q oncogenes SEC62 and SOX2 on lymphatic metastasis and clinical outcome of head and neck squamous cell carcinomas.
    Bochen F; Adisurya H; Wemmert S; Lerner C; Greiner M; Zimmermann R; Hasenfus A; Wagner M; Smola S; Pfuhl T; Bozzato A; Al Kadah B; Schick B; Linxweiler M
    Oncotarget; 2017 Jan; 8(3):4922-4934. PubMed ID: 28002801
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.